Entrada Therapeutics News and Activities

Presence

Entrada Therapeutics develops medicines for serious diseases. It provides intracellular therapy platforms, research services, and drug candidates for pharmaceutical partners, healthcare providers, and patients with genetic and neuromuscular conditions.

Entrada Therapeutics products and services overview:

  • Therapeutic platforms
  • Drug discovery
  • Genetic medicines
  • Neuromuscular therapies
  • Research partnerships

Revenue: ~$149 million

Employees: 210

Headquarters: Boston, United States (USA)


Entrada Therapeutics is one of the...

Entrada Therapeutics is a company listed under the stock ticker TRDA (US).

Acquisition, funding and merger involving Entrada Therapeutics.

Executives

View the org chart displaying its 30 main executives

Most searched biographies at Entrada Therapeutics

Create your alert
to follow the executive moves at Entrada Therapeutics.

Biotechnology

Entrada Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Entrada Therapeutics
Social media about Entrada Therapeutics

Get in Touch

Call Entrada Therapeutics at +1 646...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board